Winston Kung's Net Worth

$535 Thousand

Estimate Recalculated Apr 23, 2024 03:08PM EST

Who is Winston Kung?

Winston Kung does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., Alliqua BioMedical, Inc., and Janux Therapeutics, Inc..

SEC CIK

Winston Kung's CIK is 0001666963

Past Insider Trading and Trends

2021 was Winston Kung's most active year for acquiring shares with 6 total transactions. Winston Kung's most active month to acquire stocks was the month of April. 2021 was Winston Kung's most active year for disposing of shares, totalling 10 transactions. Winston Kung's most active month to dispose stocks was the month of July. 2021 saw Winston Kung paying a total of $74,060.00 for 73,337 shares, this is the most they've acquired in one year. In 2021 Winston Kung cashed out on 43,725 shares for a total of $607,802.85, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.79

COO, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 12
Form 4
-19.45%
-2.56K
—
—
10.6K
Nov 25
Form 4
+60.61%
4K
$3.22
$12,880.00
10.6K
Apr 20
Form 4
—
0
—
—
0
Feb 10
Form 4
-29.22%
-2.73K
—
—
6.6K
Dec 30
Form 4
+312.50%
5K
$3.22
$16,100.00
6.6K
Aug 19
Form 4
—
0
$18.52
-$137,687.85
1.6K
Scheduled
Aug 3
Form 4
—
0
$18.49
-$137,385.00
1.6K
Scheduled
Jul 8
Form 4
—
0
—
—
0
May 12
Form 4
—
0
$18.49
-$137,385.00
1.6K
Scheduled
Jun 4
Form 4
—
0
$18.49
-$137,385.00
1.6K
Scheduled
May 3
Form 4
∞
1.6K
$3.22
$5,152.00
1.6K
Dec 8
Form 3
—
0
—
—
0
No matching records found

Alliqua BioMedical, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Janux Therapeutics, Inc. (JANX) Snapshot price: $8.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Sep 21
Form 3
—
0
—
—
0
No matching records found

ArriVent Biopharma, Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found